Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression

(2018) Douglas C Bauer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

(2016) Paul D. Miller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

(2016) Felicia Cosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postmenopausal Osteoporosis

(2016) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

(2016) T. Nakamura et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women

(2015) Susan L. Greenspan et al.   JAMA Internal Medicine

Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

(2014) Toshitaka Nakamura et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis

(2013) Takuo Fujita et al.   CALCIFIED TISSUE INTERNATIONAL

Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial

(2013) Sydney Bonnick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

(2012) Toshitaka Nakamura et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Benefits and Risks of Bisphosphonate Therapy for Osteoporosis

(2012) Sundeep Khosla et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

(2012) Steven Boonen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

(2010) Steven R Cummings et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

(2010) Akira Itabashi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lasofoxifene in Postmenopausal Women with Osteoporosis

(2010) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis

(2009) Yuxiang Yan et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

(2008) Stuart L Silverman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective

(2008) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

(2008) Henry G. Bone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE